mardi 17 novembre 2015

Onco Actu du 17 novembre 2015

4. Dépistage, diagnostic et pronostic

France's Mauna Kea eyes surgical technology partnership by end 2015 [Reuters]

4.1 Dép., diag. & prono. - Prostate

EMUC15: Study shows prostate cancer screening under age of 55 may be of limited value [EAU]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

Why FDA Should Oversee Laboratory Developed Tests [FDA]

5. Traitements

Research points to why some colorectal cancers recur after treatment [MD Anderson Cancer Center]

Q&A With Raymond DuBois, MD, PhD, on Colorectal Cancer Prevention and Treatment [CANCER RESEARCH Catalyst]

5.10 Traitements - Essais

Gilead’s Zydelig® Combined with Bendamustine and Rituximab Shows Superior Efficacy to Bendamustine/Rituximab in Phase 3 Study of Patients with Relapsed Chronic Lymphocytic Leukemia [Gilead]

5.2 Pharma

U.S. Food and Drug Administration Accepts for Priority Review the Supplemental Biologics License Application for Opdivo (nivolumab) in Patients with Advanced Renal Cell Carcinoma [BMS]

5.2.3 Pharma - économie

Clovis Blowup Conjures Bad Biotech Memories of ImClone Darkness [TheStreet]

Clovis shares dive as FDA asks for more data on lung cancer drug [Reuters]

5.3.4 Traitements - AMM (FDA, EMA)

J&J nabs an early OK for 'breakthrough' multiple myeloma blockbuster contender Darzalex [FierceBiotech]

DARZALEX® (daratumumab) Approved by U.S. FDA: First Human Anti-CD38 Monoclonal Antibody Available for the Treatment of Multiple Myeloma [Johnson & Johnson]

FDA approves Darzalex for patients with previously treated multiple myeloma [FDA]

FDA approves J&J drug for advanced multiple myeloma [Reuters]

5.4 Traitements - Economie

Breast cancer drug Kadcyla 'too expensive' for NHS [BBC News]

Postcode lottery for cancer drug as Nice rules Kadcyla too expensive [The Guardian]

Roche breast cancer drug at center of UK pricing row [Reuters]

5.7.1 SABCS-communiqués

Puma Biotechnology to Present Data at the San Antonio Breast Cancer Symposium [Puma Biotechnology]

Genomic Health Announces Presentation of Eight Oncotype DX® Studies at the 2015 CTRC-AACR San Antonio Breast Cancer Symposium [Genomic Health]

6.10 Politiques

Former Health Secretary Andrew Lansley takes on Roche advisory role [Pharmafile]

6.7 DMP, Big Data & applis

Survey Shows Consumers Unlikely to Share Data with Tech Companies [MIT Technology Review]